BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

456 related articles for article (PubMed ID: 27459871)

  • 1. Natriuretic peptides as biomarkers of cardiac endocrine function in heart failure: new challenges and perspectives.
    Clerico A; Passino C; Franzini M; Emdin M
    Future Cardiol; 2016 Sep; 12(5):573-84. PubMed ID: 27459871
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Natriuretic peptides in heart failure and acute coronary syndrome.
    Gaggin HK; Januzzi JL
    Clin Lab Med; 2014 Mar; 34(1):43-58, vi. PubMed ID: 24507786
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic Accuracy of Natriuretic Peptides for Heart Failure in Patients with Pleural Effusion: A Systematic Review and Updated Meta-Analysis.
    Han ZJ; Wu XD; Cheng JJ; Zhao SD; Gao MZ; Huang HY; Gu B; Ma P; Chen Y; Wang JH; Yang CJ; Yan ZH
    PLoS One; 2015; 10(8):e0134376. PubMed ID: 26244664
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Natriuretic peptides and the prevalence of congestive heart failure in patients with pacemakers.
    Gwechenberger M; Huelsmann M; Graf S; Berger R; Bonderman D; Stanek B; Rauscha F; Pacher R
    Eur J Clin Invest; 2004 Dec; 34(12):811-7. PubMed ID: 15606723
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Natriuretic Peptides in Heart Failure: Atrial and B-type Natriuretic Peptides.
    Maisel AS; Duran JM; Wettersten N
    Heart Fail Clin; 2018 Jan; 14(1):13-25. PubMed ID: 29153197
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The impact of cardiac natriuretic peptide determination on the diagnosis and management of heart failure.
    Mair J; Hammerer-Lercher A; Puschendorf B
    Clin Chem Lab Med; 2001 Jul; 39(7):571-88. PubMed ID: 11522102
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Better treatment of heart failure by measurements of natriuretic peptides. There are still remaining problems when it comes to the interpretation of measurement levels].
    Lindstedt G; Dahlström U; Fernlund P; Schaufelberger M; Stridsberg M
    Lakartidningen; 2001 Oct; 98(41):4444-8, 4450-2. PubMed ID: 11699251
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic accuracy of natriuretic peptides for acute heart failure: a review.
    Zhou SL; Zhang J; Song TT; Li X; Wang HX
    Eur Rev Med Pharmacol Sci; 2018 Apr; 22(8):2415-2420. PubMed ID: 29762843
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The potential role of natriuretic peptides and other biomarkers in heart failure diagnosis, prognosis and management.
    Ibrahim N; Januzzi JL
    Expert Rev Cardiovasc Ther; 2015; 13(9):1017-30. PubMed ID: 26198476
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Natriuretic peptides in the diagnosis and management of chronic heart failure.
    Boerrigter G; Costello-Boerrigter LC; Burnett JC
    Heart Fail Clin; 2009 Oct; 5(4):501-14. PubMed ID: 19631175
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Natriuretic peptides in heart failure].
    Emdin M; Poletti R; Giannoni A; Mazzei MG; Mammini C; Gabutti A; Agazio A; Caprioli R; Passino C
    G Ital Nefrol; 2006; 23 Suppl 34():S32-7. PubMed ID: 16633992
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical relevance of non-cardiac determinants of natriuretic peptide levels.
    Passino C; Poletti R; Fontana M; Vergaro G; Prontera C; Gabutti A; Giannoni A; Emdin M; Clerico A
    Clin Chem Lab Med; 2008; 46(11):1515-23. PubMed ID: 19012517
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Natriuretic Peptides as Biomarkers for Congestive States: The Cardiorenal Divergence.
    Koratala A; Kazory A
    Dis Markers; 2017; 2017():1454986. PubMed ID: 28701807
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [ANMCO/ELAS/SIBioC Consensus document: Recommendations for the use of cardiac biomarkers in heart failure patients].
    Aspromonte N; Gulizia MM; Clerico A; Di Tano G; Emdin M; Feola M; Iacoviello M; Latini R; Mortara A; Valle R; Misuraca G; Passino C; Masson S; Aimo A; Ciaccio M; Migliardi M
    G Ital Cardiol (Rome); 2016 Sep; 17(9):615-656. PubMed ID: 27869886
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biomarkers and diagnostics in heart failure.
    Gaggin HK; Januzzi JL
    Biochim Biophys Acta; 2013 Dec; 1832(12):2442-50. PubMed ID: 23313577
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular forms of natriuretic peptides in heart failure and their implications.
    Xu-Cai YO; Wu Q
    Heart; 2010 Mar; 96(6):419-24. PubMed ID: 19451138
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Atrial natriuretic peptide(ANP), brain natriuretic peptide (BNP), C-type natriuretic peptide (CNP)].
    Tsujino M; Hirata Y
    Nihon Rinsho; 2010 Jul; 68 Suppl 7():619-22. PubMed ID: 20960840
    [No Abstract]   [Full Text] [Related]  

  • 18. B-type natriuretic peptide: a new tool in the armamentarium used to accurately diagnose heart failure.
    Caboral M; Mitchell J
    Prog Cardiovasc Nurs; 2003; 18(4):190-3. PubMed ID: 14605520
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel heart failure biomarkers: why do we fail to exploit their potential?
    Piek A; Du W; de Boer RA; Silljé HHW
    Crit Rev Clin Lab Sci; 2018 Jun; 55(4):246-263. PubMed ID: 29663841
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical significance of natriuretic peptides and cyclic GMP in hemodialysis patients with coronary artery disease.
    Osajima A; Okazaki M; Kato H; Anai H; Tsuda Y; Segawa K; Tanaka H; Tamura M; Takasugi M; Nakashima Y
    Am J Nephrol; 2001; 21(2):112-9. PubMed ID: 11359018
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.